Device maker Stryker in US$4.9bil deal for Inari

“The acquisition of Inari expands Stryker’s portfolio to provide life-saving solutions to patients who suffer from peripheral vascular diseases,” said Stryker chief executive officer Kevin Lobo. — Bloomberg

NEW YORK: Medical-device maker Stryker has agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth US$4.9bil.

The deal for Inari bolsters Stryker’s efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases.